addressing the potential role of immunotherapy in the frontline treatment of all
Published 1 year ago • 54 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
1:36
the future of frontline treatment in all: immunotherapy
-
1:58
incorporating immunotherapy in the frontline & salvage treatment of hodgkin lymphoma
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
3:47
the role of immunotherapy in the aml treatment landscape
-
3:04
immunotherapy for frontline treatment of all: inotuzumab ozogamicin and blinatumomab
-
1:03
incorporating immunotherapy into the first-line treatment of all
-
1:54
the potential role of cellular therapies and vaccines in the future treatment of mpns
-
1:03
an insight into the sequencing of immunotherapies in adults with all
-
11:51
audio described: nih hematology oncology fellowship program
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
3:13
which cancers can be treated with immunotherapy? ask a scientist
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os
-
1:16
how novel immunotherapies have impacted the treatment of r/r all
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
2:51
the optimum approach to frontline treatment of cll in 2021
-
5:11
the frontline treatment strategy for newly diagnosed aml
-
3:14
determining the optimal frontline treatment of aml
-
2:45
continuity of care for patients with hematological predispositions to aml
-
1:41
the emerging role of menin inhibitors in the treatment of npm1-mutated and kmt2a-rearranged r/r aml
-
1:39
optimizing chemotherapy in aml
-
1:16
treatment options for transplant-ineligible lymphoma patients: the growing role of immunotherapies